Péron, J., Lambert, A., Munier, S., Ozenne, B., Giai, J., Roy, P., . . . Buyse, M. (2019). Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit. J Natl Cancer Inst.
Chicago ZitierstilPéron, Julien, et al. "Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit." J Natl Cancer Inst 2019.
MLA ZitierstilPéron, Julien, et al. "Assessing Long-Term Survival Benefits of Immune Checkpoint Inhibitors Using the Net Survival Benefit." J Natl Cancer Inst 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.